Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Atracurium besylate 10mg/mL injection solution 25mL vial |
Is a |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 10mg/mL injection solution 2.5mL ampule |
Is a |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 50mg/5mL injection |
Is a |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 10mg/mL injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 10mg/mL injection solution 2.5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 100mg/10mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 50mg/5mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Atracurium besylate 50mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atracurium besilate |
Inferred relationship |
Some |
|
Product containing precisely atracurium besilate 25 milligram/2.5 milliliter conventional release solution for injection ampule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Product containing precisely atracurium besilate 25 milligram/2.5 milliliter conventional release solution for injection ampule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Product containing precisely atracurium besilate 250 milligram/25 milliliter conventional release solution for injection vial (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Product containing precisely atracurium besilate 250 milligram/25 milliliter conventional release solution for injection vial (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Product containing precisely atracurium besilate 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Product containing precisely atracurium besilate 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Atracurium besilate 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Atracurium besilate |
Inferred relationship |
Some |
1 |
Atracurium besilate 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Atracurium besilate |
Inferred relationship |
Some |
1 |